{
"NDC": {
"NDCCode": "42291-167-12",
"PackageDescription": "120 TABLET in 1 BOTTLE (42291-167-12) ",
"NDC11Code": "42291-0167-12",
"ProductNDC": "42291-167",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Capecitabine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Capecitabine",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20170414",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA204741",
"LabelerName": "AvKARE, Inc.",
"SubstanceName": "CAPECITABINE",
"StrengthNumber": "500",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2020-06-17",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20201231",
"StartMarketingDatePackage": "20170414",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}